TRANSFORMATION OF 20-HYDROXYECDYSONE ACETONIDES
955
raphy on 20 g of silica gel (eluent CHCl3 MeOH,
7:1) to isolate 0.24 g (49%) of initial compound II
(Rf 0.4) and 0.23 g (48%) of III (Rf 0.6). Product III
was identical in the melting point, [ ]D value, and
1H and 13C NMR spectra to a sample prepared as
described in a.
31.8 t (C16), 33.1 t (C4), 39.7 t (C7), 38.0 t (C12),
38.3 t (C1), 42.3 t (C24), 44.2 s (C10), 47.3 s (C13),
54.0 d (C5), 57.6 d (C17), 68.6 d (C3), 70.0 d (C2),
71.3 s (C25), 77.4 s (C20), 78.6 d (C22), 120.3 d (C15),
123.7 s (C8), 136.6 s (C9), 149.5 s (C14), 215.7 s (C6).
(20R,22R)-2 ,3 ,25-Trihydroxy-20,22-O-iso-
propylidene-5 -cholesta-7,9,14-trien-6-one (V).
A mixture of 0.1 g (0.2 mmol) of compound III,
0.05 g of 10% Pd/C, and 5 ml of chloroform was
stirred at room temperature under hydrogen until the
conversion of III reached 50% ( 3 days, TLC).
The mixture was evaporated, and the residue ( 2 ml)
was subjected to chromatography in a column charged
with 5 g of silica gel (eluent CHCl3 MeOH, 7:1) to
isolate 48 mg (48%) of initial compound III (Rf 0.6)
c. Compound VII was synthesized by the proce-
dure described in [10]; mp 124 125 C, [ ]1D7 = 9.0
13
(c = 0.7, MeOH); C NMR spectrum* (CD3OD),
,
C
ppm: 19.9 q (C18), 22.3 t (C11), 24.1 q (C19), 24.1 q
(C21), 25.1 t (C23), 27.3 t (C12), 29.0 q (C26), 29.3 q
(C27), 29.3 q and 29.7 q (20,22-Me2CO2), 32.8 t (C4),
36.9 t (C16), 39.4 t (C1), 39.8 d (C9), 40.0 s (C10),
42.0 t (C24), 51.5 d (C5), 58.8 d (C17), 68.6 d (C2),
68.6 d (C3), 71.3 s (C25), 83.1 d (C22), 84.8 s (C20),
108.2 s (20,22-Me2CO2), 121.1 d (C7), 130.2 d (C15),
and 49 mg (49%) of compound V (Rf 0.8), [ ]D18
=
113.0 (c = 0.8, CH3OH). 1H NMR spectrum
(CDCl3), , ppm (J, Hz): 0.87 s (3H, 19-H); 1.02 s
(3H, 18-H); 1.16 s (3H, 21-H); 1.20 s and 1.22 s (6H,
26-H, 27-H); 1.27 s and 1.40 s (6H, 20,22-Me2CO2);
0.71 2.86 m (14H, CH, CH2), 3.39 4.12 m (3H,
22-H, 2-H, 3-H); 6.08 s (1H, 7-H); 6.25 m (1H, 15-H,
w1/2 = 4); 6.30 m (1H, 11-H, w1/2 = 3). 13C NMR
spectrum (CDCl3), C, ppm: 19.6 q (C18), 20.8 q
158.9 s (C8), 150.4 s (C14), 206.1 s (C6). Following
the procedure described above in b, from 0.2 g
(0.4 mmol) of compound VIIc we obtained (after
chromatographic separation in a column charged with
8 g of silica gel, eluent CHCl3 MeOH, 7:1) 98 mg
(49%) of initial compound VII (Rf 0.5) and 94 mg
(47%) of compound III (Rf 0.6) which was identical
to a sample prepared as described in a.
(C21), 24.4 t (C23), 26.7 q (C19), 28.8 q (C26), 29.2 q
Podecdysone B or (20R,22R)-2 ,3 ,20,22,25-
pentahydroxy-5 -cholesta-8,14-dien-6-one (IV).
A mixture of 0.1 g (0.2 mmol) of compound III, 1 ml
of 70% acetic acid, and 94 mg of zinc chloride was
stirred for 4 h at room temperature. The mixture was
diluted with water (3 ml) and extracted with butyl
alcohol (3 10 ml). The organic layer was washed
with a saturated solution of NaCl (30 ml), dried over
MgSO4, and evaporated. The solid residue was sub-
jected to chromatography in a column charged with
5 g of silica gel (eluent CHCl3 MeOH, 7:1) to isolate
60 mg (60%) of initial compound III (Rf 0.6) and
35 mg (38%) of compound IV (Rf 0.3), mp 124
126 C, [ ]1D5 = 15.5 (c = 1.5, MeOH) (cf. [6, 7]).
(C27), 30.0 t (C16), 29.5 q and 29.7 q (20,22-Me2CO2),
31.8 t (C4), 38.7 t (C12), 41.0 t (C1), 42.0 t (C24),
43.8 s (C10), 45.7 s (C13), 49.4 d (C5), 57.0 d (C17),
66.9 d (C3), 67.5 d (C2), 70.3 s (C25), 81.6 d (C22),
82.9 s (C20), 106.9 s (20,22-Me2CO2), 116.3 d (C7),
128.9 d (C15), 131.7 d (C11), 135.2 s (C14), 143.8 s
(C8), 145.4 s (C9), 203.8 s (C6). Found, %: C 72.23;
H 8.97. C30H44O6. Calculated, %: C 71.97; H 8.86.
Podecdysone B 20,22-acetonide 25-trifluoro-
acetate or (20R,22R)-2 ,3 -dihydroxy-20,22-O-iso-
propylidene-25-trifluoroacetoxy-5 -cholesta-8,14-
dien-6-one (IX). Compound VIII was synthesized by
the procedure described in [10]; mp 104 106 C,
1
[ ]1D5 = 150.3 (c = 1.7, CHCl3); 13C NMR spectrum
(CDCl3), , ppm (J, Hz): 19.0 q (C18), 20.5 t (C11),
IR spectrum (KBr), , cm : 1650, 1710, 3400. UV
1
spectrum:
244 nm ( = 14150). H NMR spec-
max
trum (CD3OD), , ppm (J, Hz): 1.00 s (3H, 19-H);
1.04 s (3H, 18-H); 1.20 s (3H, 21-H); 1.27 s and
1.30 s (6H, 26-H, 27-H); 0.82 2.70 m (18H, CH,
CH2), 3.63 m (1H, 22-H, w1/2 = 5); 3.84 m (1H, 2-H,
w1/2 = 10); 3.94 m (1H, 3-H, w1/2 = 4); 5.44 m
(1H, 15-H, w1/2 = 3). 13C NMR spectrum (CD3OD),
21.1 q (C21), 23.1 t (C23), 23.2 q (C19), 25.0 q (C26),
25.8 q (C27), 26.7 t (C12), 26.7 q and 28.8 q (20,22-
Me2CO2), 31.6 t (C4), 36.4 t (C16), 38.1 t (C1), 38.4 d
(C9), 38.5 s (C10), 39.5 t (C24), 47.5 s (C13), 49.7 d
(C5), 57.7 d (C17), 67.2 d (C3), 67.7 d (C2), 80.8 d
(C22), 83.0 s (C20), 88.7 s (C25), 107.1 s (20,22-
C, ppm: 18.4 q (C18), 20.8 q (C21), 23.8 t (C11),
27.3 t (C23), 28.9 q (C19), 29.8 q (C26), 29.9 q (C27),
____________
1
Me2CO2), 114.3 q (CF3CO2, JCF = 286.0), 120.6 d
(C7), 128.4 d (C15), 148.9 s (C14), 155.6 s (C8),
2
156.0 q (CF3CO2, JCF = 41.4), 203.6 s (C6). A mix-
*
The signal from C13 is overlapped by the solvent multiplet
(
49 ppm).
ture of 0.2 g (0.33 mmol) of compound VIII, 0.05 g
C
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 39 No. 7 2003